Ketamine Infusion Therapy for Depression & PTSD | Turnwell Ketamine Infusion Therapy for Depression & PTSD | Turnwell
Skip to main content
Rapid-Acting • Monitored Clinical Setting • Tampa Bay, FL

IV Ketamine Therapy for Depression and PTSD

IV ketamine treatment room at Turnwell Mental Health

If depression or PTSD have not responded to multiple medications, you are probably not out of options. IV ketamine works on a different brain pathway than standard antidepressants, which is why some patients find relief when nothing else has. Effects can emerge within hours to days rather than weeks. Administered in a monitored clinical setting at Turnwell of Tampa Bay.

Rapid-Acting Relief for TRD & PTSD Board-Certified Psychiatric Supervision Tampa Bay, FL Only
Turnwell Mental Health Tampa Bay
Rapid-Acting for TRD & PTSD
Board-Certified Psychiatric Oversight
Monitored Clinical Setting
Turnwell of Tampa Bay, FL
What Is IV Ketamine Therapy

When Standard Treatments Haven't Provided Enough Relief

IV ketamine therapy delivers ketamine intravenously in a monitored clinical setting. Ketamine acts on NMDA glutamate receptors rather than on serotonin or norepinephrine pathways, making it a distinct pharmacological option for patients who have not responded to antidepressants targeting those pathways.

One of the most clinically significant features of IV ketamine is its speed of action. While antidepressants typically require four to eight weeks before producing full therapeutic benefit, ketamine often produces noticeable improvement in mood, PTSD symptoms, and suicidal ideation within hours to days of infusion. This rapid onset makes it a meaningful option for patients experiencing acute distress alongside treatment-resistant conditions.

IV ketamine at Turnwell is administered by licensed psychiatric providers in a fully monitored infusion setting. Vital signs, comfort, and clinical response are tracked throughout every session. A series of infusions is typically recommended to produce and sustain the therapeutic response.

IV Ketamine vs. Spravato

IV Ketamine
Spravato
FDA Status
Not FDA-approved for depression
FDA-approved for TRD & MDD-SI
Insurance
Typically not covered
Covered by most major plans
Route
Intravenous infusion
Nasal spray
Turnwell
Tampa Bay, FL only
All 4 locations

Considering Spravato First?

If you have treatment-resistant depression, Spravato (esketamine) is FDA-approved and covered by most major insurance at all four Turnwell locations. Our team will help you understand which option is the best clinical and financial fit.

Learn About Spravato
Treatment Process

What IV Ketamine Therapy Looks Like at Turnwell Tampa Bay

IV ketamine follows a structured clinical protocol administered by board-certified psychiatric providers.

1

Psychiatric Evaluation

Your Turnwell psychiatrist reviews your full clinical history, prior treatment trials, current medications, and medical history to determine whether IV ketamine is appropriate and whether you are a suitable candidate.

2

Pre-Infusion Preparation

You will need someone to drive you home after each session. Most patients fast for a period before the infusion. Your provider will give you specific preparation instructions during your consultation.

3

The Infusion

IV ketamine is delivered through a small IV catheter, typically over 40 to 60 minutes. You remain awake and comfortable throughout. Many patients experience a dissociative or dreamlike state during the infusion that resolves as it concludes. Vital signs are monitored continuously.

4

Post-Infusion Monitoring

You remain at the clinic for a brief observation period after the infusion ends. As ketamine's effects resolve, most patients feel groggy or fatigued. You cannot drive on the day of your infusion.

5

Series and Follow-Up

A standard course typically involves six infusions over two to three weeks. Your clinical response is monitored throughout, and maintenance infusion options are discussed if you achieve a meaningful response.

What to Know Before Starting

You cannot drive on the day of an infusion session
IV ketamine is typically not covered by insurance; cost and payment discussed at consultation
A full psychiatric evaluation is required before your first infusion
Active psychosis or certain substance use disorders may be contraindications
If you may qualify for Spravato (FDA-approved, insurance-covered), our team will discuss both options

Tampa Bay Location

1001 S MacDill Ave, Ste 800
Tampa, FL 33629

(813) 344-5074

If you or someone you know is in crisis, please call or text 988 (Suicide & Crisis Lifeline) or go to your nearest emergency room. Turnwell is not an emergency or crisis facility.

Call 988 Now
FAQ

IV Ketamine Therapy Questions Answered

What is IV ketamine therapy?
IV ketamine therapy delivers ketamine intravenously in a monitored clinical setting. It acts on NMDA glutamate receptors and is used for treatment-resistant depression, PTSD, and severe anxiety that has not responded to standard treatments. Many patients report meaningful improvement within hours to days of their first infusion.
How is IV ketamine different from Spravato?
Both are ketamine-based treatments acting on NMDA receptors, but they differ importantly. Spravato (esketamine) is FDA-approved as a nasal spray and is typically covered by most major insurance. IV ketamine delivers ketamine intravenously, is not FDA-approved specifically for depression, and is typically not covered by insurance. If you may qualify for Spravato, Turnwell will discuss both options during your consultation.
Is IV ketamine covered by insurance?
IV ketamine therapy is typically not covered by most insurance plans because it does not have FDA approval specifically for depression or PTSD. Turnwell discusses cost and payment options during your consultation. For qualifying patients, Spravato (esketamine) is an FDA-approved, insurance-covered alternative that our team will also evaluate your candidacy for.
How quickly does IV ketamine work?
Many patients report meaningful improvement in depression symptoms within hours to days of IV ketamine infusion, making it one of the fastest-acting interventions in psychiatric care. Results vary by individual, and a series of six infusions over two to three weeks is typically recommended to produce a sustained response.
Who is a candidate for IV ketamine?
IV ketamine is typically considered for adults with treatment-resistant depression, PTSD, or severe anxiety who have not responded to multiple standard treatments. A thorough psychiatric evaluation at Turnwell of Tampa Bay is required to determine candidacy. Patients with active psychosis or certain substance use disorders may not be eligible.
Where is IV ketamine available at Turnwell?
IV ketamine therapy at Turnwell is available exclusively at our Tampa Bay, FL location: 1001 S MacDill Ave, Ste 800, Tampa, FL 33629. Call (813) 344-5074. Spravato, the FDA-approved alternative, is available at all four Turnwell locations.
Related Services

Other Advanced Options at Turnwell

FDA-Approved

Spravato (Esketamine)

FDA-approved esketamine nasal spray for treatment-resistant depression. Covered by most insurance. All four Turnwell locations.

Learn about Spravato
FDA-Cleared

TMS Therapy

Non-invasive FDA-cleared treatment for treatment-resistant depression and OCD. Covered by most insurance at Alpharetta, Charleston, and Tampa Bay.

Learn about TMS
Condition Guide

Treatment-Resistant Depression

A comprehensive guide to TRD including TMS, Spravato, and IV ketamine options at Turnwell and what qualifies as treatment-resistant.

Learn about TRD

Most Major Insurance Plans Accepted

We verify your benefits before your first appointment and handle prior authorization for TMS and Spravato.

AetnaBlue Cross Blue ShieldCignaUnited HealthcareMedicareMedicaidTricare& More

Coverage varies by plan and medical necessity criteria. Contact us to verify your specific benefits before your first appointment.

Trusted Resources

Looking for additional information about mental health conditions and treatment options? These organizations provide reliable, evidence-based guidance.

Dr. Derek Robben M.D., Medical Director Turnwell Tampa Bay
Medically Reviewed By
Dr. Derek Robben, M.D.
Board-Certified Psychiatrist · Medical Director, Turnwell Mental Health of Tampa Bay · IV Ketamine Provider
One Conversation Is All It Takes

Find Out Whether Ketamine Therapy Is a Fit

Our Tampa Bay clinical team will review your treatment history, discuss whether you meet candidacy criteria for IV ketamine or Spravato, and answer every question you have about what the process looks like — before anything is scheduled. There is no obligation. Most patients are seen within a few days of reaching out.

Spravato Treatment for Depression | Turnwell Mental Health
Skip to main content
FDA-Approved • All 4 Locations • Most Insurance Covered

Spravato Treatment for Depression When Antidepressants Haven't Worked

Spravato treatment room at Turnwell Mental Health

When you have tried multiple antidepressants and none of them have worked, it is natural to wonder whether anything will. Spravato was developed for exactly that situation. FDA-approved for treatment-resistant depression, it works on a different brain pathway than traditional antidepressants, which is why it can help when standard medications have not. Sessions are administered in-office, and most major insurance plans cover it when the medical criteria are met.

FDA-Approved for Treatment-Resistant Depression Available at All 4 Turnwell Locations Covered by Most Major Insurance
Spravato treatment room at Turnwell Mental Health
FDA-Approved for TRD & MDD-SI
Medically Supervised In-Office
All 4 Turnwell Locations
Medicare, Medicaid & Most Insurance
What Is Spravato

A New Mechanism When Traditional Antidepressants Fall Short

Spravato (esketamine) is the first FDA-approved nasal spray for treatment-resistant depression (TRD) and for major depressive disorder with suicidal ideation (MDD-SI). Developed by Janssen Pharmaceutica and approved by the FDA in 2019, it offers a clinically distinct option for patients who have not responded to adequate trials of standard antidepressant medications.

Traditional antidepressants primarily act on monoamine neurotransmitters like serotonin, norepinephrine, and dopamine. Spravato works on a fundamentally different system: the NMDA glutamate receptor. This difference in mechanism explains both why Spravato can work for patients when standard medications have not, and why it often produces noticeable improvement faster.

Spravato is self-administered as a nasal spray under the direct supervision of a certified healthcare provider. Patients remain in the clinical setting for at least two hours after each dose for monitoring. It is available only through a certified provider under the FDA REMS program, which ensures safety standards are maintained at every step.

Spravato by the Numbers

2019
Year FDA approved Spravato for treatment-resistant depression
1–2 wks
Timeframe in which many patients begin to notice improvement
2 hrs
Post-dose observation time at the clinic after each Spravato session
4
Turnwell locations where Spravato treatment is available today
How Spravato Works

A Fundamentally Different Mechanism Than Standard Antidepressants

Understanding how Spravato differs from traditional antidepressants helps explain why it can be effective for patients who have not responded to them, and why it works more quickly.

Traditional Antidepressants
Spravato (Esketamine)
Target
Serotonin, norepinephrine, dopamine receptors
NMDA glutamate receptors
Onset
4 to 8 weeks for full effect
Often noticeable within 1 to 2 weeks
Administration
Daily oral tablets or capsules at home
Nasal spray, in-office, under medical supervision
Insurance
Generally covered for most diagnoses
Covered for TRD and MDD-SI when criteria met
FDA status
Approved for depression, varies by drug
Approved specifically for TRD and MDD-SI

The NMDA Receptor Difference

The prevailing theory behind treatment-resistant depression involves disrupted glutamate signaling and reduced synaptic plasticity in mood-regulating brain regions. By blocking NMDA glutamate receptors, esketamine rapidly restores synaptic connections that depression has weakened, producing improvement that many patients notice in a matter of days rather than weeks.

This mechanism also explains why Spravato can be effective for patients who have tried multiple SSRIs or SNRIs without success. Because it targets a completely different neurological pathway, prior non-response to monoamine-based antidepressants does not predict non-response to Spravato.

Spravato is typically used alongside an oral antidepressant as part of a coordinated treatment plan managed by your Turnwell psychiatrist.

Who Is a Candidate

Is Spravato Right for You?

Spravato has FDA approval for two specific indications. Insurance coverage aligns with these criteria. Your Turnwell psychiatrist will confirm whether you meet the clinical threshold during your evaluation.

Treatment-Resistant Depression (TRD)

Spravato is FDA-approved for adults with major depressive disorder who have not responded adequately to at least two different antidepressant medications taken at an appropriate dose and for an appropriate duration. This is the most common indication for Spravato at Turnwell.

MDD with Suicidal Ideation (MDD-SI)

Spravato is also FDA-approved for adults with major depressive disorder experiencing acute suicidal ideation or behavior. In this context, Spravato is used as a short-term intervention to rapidly reduce suicidal thoughts while longer-term treatment is established.

Who May Not Be a Candidate

Spravato is not appropriate for everyone. Contraindications include certain vascular conditions, history of aneurysm, and active psychosis. Patients with a history of substance use disorder require careful clinical evaluation. Your Turnwell provider reviews your full medical and psychiatric history before recommending Spravato.

Required Criteria for Insurance Coverage

Most insurance plans require documentation of two failed antidepressant trials at adequate dose and duration to authorize Spravato. Our team reviews your treatment history, gathers necessary clinical documentation, and handles the prior authorization process before your first session.

The Spravato Experience

What a Spravato Session Looks Like at Turnwell

Spravato is administered under a structured clinical protocol required by the FDA REMS program. Here is how each session and the overall treatment timeline are structured.

1

Psychiatric Evaluation and Insurance Verification

Your Turnwell psychiatrist confirms your TRD or MDD-SI diagnosis, reviews your antidepressant history, and determines whether Spravato is clinically appropriate. Our team then verifies your Spravato benefits and submits prior authorization.

2

Arriving for Your Session

You arrive at the clinic for your scheduled Spravato session. Because Spravato can cause temporary dizziness and altered perception, you cannot drive yourself home. Arrange for a trusted person to pick you up or use a rideshare service after each session.

3

Self-Administration Under Supervision

Under direct medical supervision, you self-administer the Spravato nasal spray. Your provider instructs you on correct technique and monitors you throughout the session. Most patients rest comfortably in a clinical chair during the session.

4

Two-Hour Observation Period

You remain at the clinic for at least two hours after administration. Clinical staff monitor your blood pressure, any dissociative symptoms, and overall response. These effects typically resolve fully within the observation window.

5

Treatment Schedule and Maintenance

The induction phase involves two sessions per week for four weeks. The maintenance phase typically transitions to weekly sessions for four weeks, then every one to two weeks depending on your clinical response. Your Turnwell provider monitors your progress throughout and adjusts the schedule as needed.

What to Know Before Your First Session

Do not drive or operate heavy machinery on the day of your session
Arrange transportation to and from each appointment in advance
Avoid food for at least two hours and liquids for at least 30 minutes before each session
You will remain in the clinic for at least two hours after each dose
Temporary dissociation, dizziness, and nausea are common during sessions and typically resolve before you leave
Spravato is used alongside an oral antidepressant, not as a standalone treatment

REMS Program Certification

Spravato is available only through the FDA's REMS (Risk Evaluation and Mitigation Strategy) program. All four Turnwell locations are certified Spravato treatment sites and comply with REMS monitoring and documentation requirements.

Spravato Is Covered by Most Major Insurance

Our team handles prior authorization and works directly with your insurance plan to confirm coverage before your first session.

Aetna Blue Cross Blue Shield Cigna United Healthcare Medicare Medicaid

Spravato coverage requires documentation of treatment-resistant depression or MDD with suicidal ideation. Coverage varies by plan and criteria. Contact us to verify your specific Spravato benefits.

Spravato Locations

Spravato Treatment Available at All Four Turnwell Locations

Every Turnwell location is a certified Spravato treatment site. Each is staffed by board-certified psychiatrists and equipped with the monitoring required by the FDA REMS program.

Georgia

Alpharetta, GA

11125 Jones Bridge Rd, Ste 100
Alpharetta, GA 30022

(678) 383-0008 View Location
South Carolina

Charleston, SC

600 Seacoast Pkwy, Ste 200
Mt. Pleasant, SC 29464

(843) 868-2005 View Location
Florida

Aventura, FL

2999 NE 191st St, Ste 600
Aventura, FL 33180

(786) 981-0640 View Location
Florida

Tampa Bay, FL

1001 S MacDill Ave, Ste 800
Tampa, FL 33629

(813) 344-5074 View Location

If you or someone you know is in crisis, please call or text 988 (Suicide & Crisis Lifeline) or go to your nearest emergency room. Turnwell is not an emergency or crisis facility.

Call 988 Now
Frequently Asked Questions

Spravato Questions, Answered

What is Spravato (esketamine)?
Spravato (esketamine) is the FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation. It is a form of ketamine that works on NMDA glutamate receptors, a different mechanism than traditional antidepressants. It is self-administered in-office under medical supervision at all four Turnwell locations.
Is Spravato covered by insurance?
Yes. Spravato is covered by most major insurance plans, including Medicare, Medicaid, Aetna, Blue Cross Blue Shield, Cigna, and United Healthcare, when medically indicated. Coverage typically requires documentation that the patient meets criteria for treatment-resistant depression or MDD with suicidal ideation. Turnwell verifies your Spravato benefits and handles prior authorization before your first session.
How quickly does Spravato work?
Spravato often produces noticeable improvement in depressive symptoms faster than traditional antidepressants. Some patients report meaningful improvement within the first one to two weeks of treatment. This rapid onset is one of the key clinical advantages of Spravato for patients experiencing significant or acute depression symptoms.
How is Spravato administered?
Spravato is self-administered as a nasal spray under direct medical supervision in a certified clinical setting. Patients remain in the office for at least two hours after each dose for monitoring. You cannot drive on the day of a Spravato session. Treatment is typically given twice per week for the first four weeks, then weekly or every two weeks for maintenance.
Who is a candidate for Spravato?
Spravato is FDA-approved for adults with treatment-resistant depression (major depressive disorder that has not responded to at least two different antidepressants at adequate dose and duration) and for adults with major depressive disorder with suicidal ideation. A psychiatric evaluation confirms diagnosis and candidacy.
What are the side effects of Spravato?
Common side effects include temporary dissociation, dizziness, nausea, and elevated blood pressure during the session. These effects typically resolve within the two-hour observation period before you leave the clinic. Because of these transient effects, you cannot drive on the day of treatment. Spravato is available only through certified providers under the FDA REMS program, which ensures proper monitoring.
What is the difference between Spravato and IV ketamine?
Both are ketamine-based treatments acting on NMDA receptors, but they differ in important ways. Spravato (esketamine) is an FDA-approved nasal spray and is covered by most major insurance plans. IV ketamine delivers ketamine intravenously in a monitored setting and is typically not covered by insurance. Spravato is available at all four Turnwell locations. IV ketamine therapy is available at Turnwell of Tampa Bay only.
Can Spravato be used with my current antidepressant?
Yes. Spravato is intended to be used in combination with an oral antidepressant, not as a standalone treatment. Your Turnwell psychiatrist will coordinate any adjustments to your current medication regimen as part of your overall treatment plan.
Trusted Clinical Resources

The following organizations provide peer-reviewed clinical information about Spravato, esketamine, and treatment-resistant depression.

Dr. Jose I. Reyes, M.D., Board-Certified Psychiatrist and Spravato Provider, Turnwell Mental Health
Medically Reviewed By
Dr. Jose I. Reyes, M.D.
Board-Certified Psychiatrist · Spravato-Certified Provider · Turnwell Mental Health of Alpharetta
One Conversation Is All It Takes to Start

See Whether Spravato Is an Option for You

Reach out and our team will review your antidepressant history, confirm whether you meet eligibility criteria, walk you through what a Spravato session looks like, and verify your insurance benefits — all before you commit to anything. There is no pressure. Most patients speak with a member of our clinical team within a few days of reaching out.

Skip to main content
Rapid-Acting • Monitored Clinical Setting • Tampa Bay, FL

IV Ketamine Therapy for Depression and PTSD

Turnwell Mental Health Tampa Bay

If depression or PTSD have not responded to multiple medications, you are probably not out of options. IV ketamine works on a different brain pathway than standard antidepressants, which is why some patients find relief when nothing else has. Effects can emerge within hours to days rather than weeks. Administered in a monitored clinical setting at Turnwell of Tampa Bay.

Rapid-Acting Relief for TRD & PTSD Board-Certified Psychiatric Supervision Tampa Bay, FL Only
Turnwell Mental Health Tampa Bay
Rapid-Acting for TRD & PTSD
Board-Certified Psychiatric Oversight
Monitored Clinical Setting
Turnwell of Tampa Bay, FL
What Is IV Ketamine Therapy

When Standard Treatments Haven't Provided Enough Relief

IV ketamine therapy delivers ketamine intravenously in a monitored clinical setting. Ketamine acts on NMDA glutamate receptors rather than on serotonin or norepinephrine pathways, making it a distinct pharmacological option for patients who have not responded to antidepressants targeting those pathways.

One of the most clinically significant features of IV ketamine is its speed of action. While antidepressants typically require four to eight weeks before producing full therapeutic benefit, ketamine often produces noticeable improvement in mood, PTSD symptoms, and suicidal ideation within hours to days of infusion. This rapid onset makes it a meaningful option for patients experiencing acute distress alongside treatment-resistant conditions.

IV ketamine at Turnwell is administered by licensed psychiatric providers in a fully monitored infusion setting. Vital signs, comfort, and clinical response are tracked throughout every session. A series of infusions is typically recommended to produce and sustain the therapeutic response.

IV Ketamine vs. Spravato

IV Ketamine
Spravato
FDA Status
Not FDA-approved for depression
FDA-approved for TRD & MDD-SI
Insurance
Typically not covered
Covered by most major plans
Route
Intravenous infusion
Nasal spray
Turnwell
Tampa Bay, FL only
All 4 locations

Considering Spravato First?

If you have treatment-resistant depression, Spravato (esketamine) is FDA-approved and covered by most major insurance at all four Turnwell locations. Our team will help you understand which option is the best clinical and financial fit.

Learn About Spravato
Treatment Process

What IV Ketamine Therapy Looks Like at Turnwell Tampa Bay

IV ketamine follows a structured clinical protocol administered by board-certified psychiatric providers.

1

Psychiatric Evaluation

Your Turnwell psychiatrist reviews your full clinical history, prior treatment trials, current medications, and medical history to determine whether IV ketamine is appropriate and whether you are a suitable candidate.

2

Pre-Infusion Preparation

You will need someone to drive you home after each session. Most patients fast for a period before the infusion. Your provider will give you specific preparation instructions during your consultation.

3

The Infusion

IV ketamine is delivered through a small IV catheter, typically over 40 to 60 minutes. You remain awake and comfortable throughout. Many patients experience a dissociative or dreamlike state during the infusion that resolves as it concludes. Vital signs are monitored continuously.

4

Post-Infusion Monitoring

You remain at the clinic for a brief observation period after the infusion ends. As ketamine's effects resolve, most patients feel groggy or fatigued. You cannot drive on the day of your infusion.

5

Series and Follow-Up

A standard course typically involves six infusions over two to three weeks. Your clinical response is monitored throughout, and maintenance infusion options are discussed if you achieve a meaningful response.

What to Know Before Starting

You cannot drive on the day of an infusion session
IV ketamine is typically not covered by insurance; cost and payment discussed at consultation
A full psychiatric evaluation is required before your first infusion
Active psychosis or certain substance use disorders may be contraindications
If you may qualify for Spravato (FDA-approved, insurance-covered), our team will discuss both options

Tampa Bay Location

1001 S MacDill Ave, Ste 800
Tampa, FL 33629

(813) 344-5074

If you or someone you know is in crisis, please call or text 988 (Suicide & Crisis Lifeline) or go to your nearest emergency room. Turnwell is not an emergency or crisis facility.

Call 988 Now
FAQ

IV Ketamine Therapy Questions Answered

What is IV ketamine therapy?
IV ketamine therapy delivers ketamine intravenously in a monitored clinical setting. It acts on NMDA glutamate receptors and is used for treatment-resistant depression, PTSD, and severe anxiety that has not responded to standard treatments. Many patients report meaningful improvement within hours to days of their first infusion.
How is IV ketamine different from Spravato?
Both are ketamine-based treatments acting on NMDA receptors, but they differ importantly. Spravato (esketamine) is FDA-approved as a nasal spray and is typically covered by most major insurance. IV ketamine delivers ketamine intravenously, is not FDA-approved specifically for depression, and is typically not covered by insurance. If you may qualify for Spravato, Turnwell will discuss both options during your consultation.
Is IV ketamine covered by insurance?
IV ketamine therapy is typically not covered by most insurance plans because it does not have FDA approval specifically for depression or PTSD. Turnwell discusses cost and payment options during your consultation. For qualifying patients, Spravato (esketamine) is an FDA-approved, insurance-covered alternative that our team will also evaluate your candidacy for.
How quickly does IV ketamine work?
Many patients report meaningful improvement in depression symptoms within hours to days of IV ketamine infusion, making it one of the fastest-acting interventions in psychiatric care. Results vary by individual, and a series of six infusions over two to three weeks is typically recommended to produce a sustained response.
Who is a candidate for IV ketamine?
IV ketamine is typically considered for adults with treatment-resistant depression, PTSD, or severe anxiety who have not responded to multiple standard treatments. A thorough psychiatric evaluation at Turnwell of Tampa Bay is required to determine candidacy. Patients with active psychosis or certain substance use disorders may not be eligible.
Where is IV ketamine available at Turnwell?
IV ketamine therapy at Turnwell is available exclusively at our Tampa Bay, FL location: 1001 S MacDill Ave, Ste 800, Tampa, FL 33629. Call (813) 344-5074. Spravato, the FDA-approved alternative, is available at all four Turnwell locations.
Related Services

Other Advanced Options at Turnwell

FDA-Approved

Spravato (Esketamine)

FDA-approved esketamine nasal spray for treatment-resistant depression. Covered by most insurance. All four Turnwell locations.

Learn about Spravato
FDA-Cleared

TMS Therapy

Non-invasive FDA-cleared treatment for treatment-resistant depression and OCD. Covered by most insurance at Alpharetta, Charleston, and Tampa Bay.

Learn about TMS
Condition Guide

Treatment-Resistant Depression

A comprehensive guide to TRD including TMS, Spravato, and IV ketamine options at Turnwell and what qualifies as treatment-resistant.

Learn about TRD

Most Major Insurance Plans Accepted

We verify your benefits before your first appointment and handle prior authorization for TMS and Spravato.

AetnaBlue Cross Blue ShieldCignaUnited HealthcareMedicareMedicaidTricare& More

Coverage varies by plan and medical necessity criteria. Contact us to verify your specific benefits before your first appointment.

Trusted Resources

Looking for additional information about mental health conditions and treatment options? These organizations provide reliable, evidence-based guidance.

Dr. Derek Robben M.D., Medical Director Turnwell Tampa Bay
Medically Reviewed By
Dr. Derek Robben, M.D.
Board-Certified Psychiatrist · Medical Director, Turnwell Mental Health of Tampa Bay
One Conversation Is All It Takes

Find Out Whether Ketamine Therapy Is a Fit

Our Tampa Bay clinical team will review your treatment history, discuss whether you meet candidacy criteria for IV ketamine or Spravato, and answer every question you have about what the process looks like — before anything is scheduled. There is no obligation. Most patients are seen within a few days of reaching out.

Scroll to Top